<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="224569">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00159029</url>
  </required_header>
  <id_info>
    <org_study_id>152910-HMO-CTIL</org_study_id>
    <nct_id>NCT00159029</nct_id>
  </id_info>
  <brief_title>Genetics of Alpha Thalassemia in Israeli Ethnic Groups</brief_title>
  <official_title>Haplotype Analysis of Alpha Globin Genes in Israeli Ethnic Groups</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hadassah Medical Organization</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hadassah Medical Organization</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Alpha thalassemia causes mild anemia and is found in many ethnic groups. Usually it is found
      in regions where malaria is endemic. We have found that alpha thalassemia is common in
      Ashkenazim, whose countries of origin are in temperate climates.

      We are analyzing the alpha globin genes of individuals of many ethnic groups and will
      compare to try to define the origin of thalassemia in these individuals of European
      extraction.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Alpha thalassemia causes mild anemia and is found in many ethnic groups. Usually it is found
      in regions where malaria is endemic. We have found that alpha thalassemia is common in
      Ashkenazim, whose countries of origin are in temperate climates.

      We are analyzing the alpha globin polymorphisms to determine the haplotypes of individuals
      of many ethnic groups and will compare to try to define the origin of thalassemia in these
      individuals of European extraction.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>April 2004</start_date>
  <completion_date type="Anticipated">April 2012</completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Alpha Thalassemia</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      DNA isolated from peripheral blood.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who come to Hadassah Hospital for anemia with microcytosis who are found to have
        alpha thalassemia.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  diagnosis of deletional alpha thalassemia

        Exclusion Criteria:

          -  under age 18
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Deborah Rund, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hadassah Medical Organization</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Deborah Rund, MD</last_name>
    <phone>00 972 2 6778712</phone>
    <email>rund@cc.huji.ac.il</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Hadas Lemberg, PhD</last_name>
    <phone>00 972 2 6777572</phone>
    <email>lhadas@hadassah.org.il</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hadassah Medical Organization</name>
      <address>
        <city>Jerusalem</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Arik Tzukert, DMD</last_name>
      <phone>00 972 2 6776095</phone>
      <email>arik@hadassah.org.il</email>
    </contact>
    <contact_backup>
      <last_name>Hadas Lemberg, PhD</last_name>
      <phone>00 972 2 6777572</phone>
      <email>lhadas@hadassah.org.il</email>
    </contact_backup>
    <investigator>
      <last_name>Deborah Rund, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <reference>
    <citation>Rund D, Filon D, Jackson N, Asher N, Oron-Karni V, Sacha T, Czekalska S, Oppenheim A. An unexpectedly high frequency of heterozygosity for alpha-thalassemia in Ashkenazi Jews. Blood Cells Mol Dis. 2004 Jul-Aug;33(1):1-3.</citation>
    <PMID>15223003</PMID>
  </reference>
  <verification_date>June 2011</verification_date>
  <lastchanged_date>June 22, 2011</lastchanged_date>
  <firstreceived_date>September 9, 2005</firstreceived_date>
  <responsible_party>
    <name_title>Deborah Rund</name_title>
    <organization>Hadassah Medical Organization</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Thalassemia</mesh_term>
    <mesh_term>alpha-Thalassemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
